02-24-2004, 03:43 PM
LEAN AND MEAN
February 24, 2004 -- TAMPA - If Derek Jeter is the big loser in the Yankees' acquisition of Alex Rodriguez then Gary Sheffield and, especially, Jason Giambi are the big winners.
A-Rod already is overshadowing Jeter and every other Yankee. That is just fine with Giambi and Sheffield, whose grand jury testimony in the BALCO steroid case was going to pale to the media grand inquisition both were going to face regularly this spring.
But then A-Rod came along and now Giambi and Sheffield are behind him in both the Yankee batting order and pecking order. Since both men were snippy when questioned about illegal performance enhancers in the Legends Field clubhouse yesterday, they should be grateful that all A-Rod, all the time has diminished what would have been persistent queries about the kind of team chemistry neither wants to discuss.
No other club has two players this large ensnared in the BALCO case, though Giambi's size is in question. If you think he came up small by asking out of the World Series Game 5 lineup last year, you should see him now.
Giambi claimed he has lost only four pounds, from 232 to 228, but the clubhouse consensus was at least 15. A four-pound loss on Giambi would be near imperceptible, but he looked as if someone stuck a pin in him and let out the air, so noticeably streamlined was he in all areas, including his face.
(screen.width/2)){this.width = (this.width/2)}" onclick="javascript:if(this.width > (screen.width/2)){this.width = (this.width/2)} else {this.width = (this.width*2)}" border="0" alt='Posted image: Click to resize'>
But this is not the kind of cheating that brings suspicion about Giambi. Take a look at the 1992 Team USA picture of Giambi accompanying this column.
He was a little third baseman. It is hard to tell a decade later that it was the same person. He began to grow in bulk when Mark McGwire became his workout partner and McGwire was a user of androstenedione, legal at the time but since banned.
Giambi stresses the need to have his personal trainer with him at nearly all times. The knee injury he incurred (patella tendinitis) is one often related to steroid users and is similar to the one that ended McGwire's career.
Giambi is suddenly lean and less overly muscled as baseball's drug-testing policy grows stiffer and questions about his involvement with BALCO are intense. Giambi also was thinner - but not this thin - to begin last spring, the first with mandatory drug testing. He then bulked up significantly as the season went along.
When asked if he had ever used illegal performance enhancers, Giambi asked, "Do you mean steroids?" and then said, "No."
Sheffield described issues like this as "like a fly on my shoulder," but snapped at the reporter who first asked about steroids and barked "next question" each time he finished a response about illegal drugs.
Giambi also was hardly all smiles in saying he would not discuss his grand jury testimony and explaining he cannot control if people remained suspicious about him.
But as off-put as Giambi and Sheffield were, this could all be far worse for them, particularly Giambi, who also would be hounded more persistently about not getting on the field against Florida in Game 5. Joe Torre surmised that this steroid issue is not "going away" soon and could lurk around his team.
However, the ferocity of the focus is greatly lessened. Today, Rodriguez and Jeter take the field together for the first time as Yankees. And these days A-Rod is the media's drug of choice.
Joel Sherman
NY Post
February 24, 2004 -- TAMPA - If Derek Jeter is the big loser in the Yankees' acquisition of Alex Rodriguez then Gary Sheffield and, especially, Jason Giambi are the big winners.
A-Rod already is overshadowing Jeter and every other Yankee. That is just fine with Giambi and Sheffield, whose grand jury testimony in the BALCO steroid case was going to pale to the media grand inquisition both were going to face regularly this spring.
But then A-Rod came along and now Giambi and Sheffield are behind him in both the Yankee batting order and pecking order. Since both men were snippy when questioned about illegal performance enhancers in the Legends Field clubhouse yesterday, they should be grateful that all A-Rod, all the time has diminished what would have been persistent queries about the kind of team chemistry neither wants to discuss.
No other club has two players this large ensnared in the BALCO case, though Giambi's size is in question. If you think he came up small by asking out of the World Series Game 5 lineup last year, you should see him now.
Giambi claimed he has lost only four pounds, from 232 to 228, but the clubhouse consensus was at least 15. A four-pound loss on Giambi would be near imperceptible, but he looked as if someone stuck a pin in him and let out the air, so noticeably streamlined was he in all areas, including his face.
(screen.width/2)){this.width = (this.width/2)}" onclick="javascript:if(this.width > (screen.width/2)){this.width = (this.width/2)} else {this.width = (this.width*2)}" border="0" alt='Posted image: Click to resize'>
But this is not the kind of cheating that brings suspicion about Giambi. Take a look at the 1992 Team USA picture of Giambi accompanying this column.
He was a little third baseman. It is hard to tell a decade later that it was the same person. He began to grow in bulk when Mark McGwire became his workout partner and McGwire was a user of androstenedione, legal at the time but since banned.
Giambi stresses the need to have his personal trainer with him at nearly all times. The knee injury he incurred (patella tendinitis) is one often related to steroid users and is similar to the one that ended McGwire's career.
Giambi is suddenly lean and less overly muscled as baseball's drug-testing policy grows stiffer and questions about his involvement with BALCO are intense. Giambi also was thinner - but not this thin - to begin last spring, the first with mandatory drug testing. He then bulked up significantly as the season went along.
When asked if he had ever used illegal performance enhancers, Giambi asked, "Do you mean steroids?" and then said, "No."
Sheffield described issues like this as "like a fly on my shoulder," but snapped at the reporter who first asked about steroids and barked "next question" each time he finished a response about illegal drugs.
Giambi also was hardly all smiles in saying he would not discuss his grand jury testimony and explaining he cannot control if people remained suspicious about him.
But as off-put as Giambi and Sheffield were, this could all be far worse for them, particularly Giambi, who also would be hounded more persistently about not getting on the field against Florida in Game 5. Joe Torre surmised that this steroid issue is not "going away" soon and could lurk around his team.
However, the ferocity of the focus is greatly lessened. Today, Rodriguez and Jeter take the field together for the first time as Yankees. And these days A-Rod is the media's drug of choice.
Joel Sherman
NY Post